About RX Biotech Private Limited
Data last updated:
RX Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 February 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2005PTC132956. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aditya Jagdishmitter Gupta and Shelly Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot At Kh No. 1020 G/F Front Side Portion Village Mundra, Extn, New Delhi, Delhi, India – 110041.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rxbiotech.in.
Company details
Contact details
RX Biotech Private Limited's registered office is in New Delhi, Delhi. Its website is rxbiotech.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot At Kh No. 1020 G/F Front Side Portion Village Mundra, Extn, New Delhi, Delhi, India – 110041
- IndustryPharma, Drug Formulation & Development
To see the full contact details of RX Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of RX Biotech is professional, scientific and technical. In detail, this covers advertising and market research.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M6 | Advertising and market research |
Financials of RX Biotech Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of RX Biotech Private Limited, buy the company report.
Board of directors of RX Biotech Private Limited
RX Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Jagdishmitter Gupta Also directs: RX Healthcare Limited, Rhone Poulenc Labs Private Limited, Rhone Pharmacie Private Limited and 1 more | Director | 14 Feb 2005 | 21 Years 8 Months | Current |
| Shelly Gupta Also directs: RX Healthcare Limited, Rhone Poulenc Labs Private Limited, Rhone Pharmacie Private Limited and 1 more | Director | 05 Sep 2018 | 8 Years 2 Months | Current |
Auditor
RX Biotech Private Limited is audited by SARDA SONI ASSOCIATES LLP for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARDA SONI ASSOCIATES LLP | FY 2020 | 117235W |
Shareholding
The shareholding of RX Biotech Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of RX Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving RX Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for RX Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
RX Biotech has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of RX Biotech Private Limited, buy the company report.
Recent activity
RX Biotech Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Shelly Gupta ceased to be Additional Director on 27 Sep 2019.
Frequently asked questions
RX Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 February 2005 (21+ years old) and is registered under CIN U24233DL2005PTC132956.
RX Biotech has 2 current directors:
- Aditya Jagdishmitter Gupta - Director
- Shelly Gupta - Director
The latest financial statements of RX Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. RX Biotech has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of RX Biotech is U24233DL2005PTC132956. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
RX Biotech was incorporated on 14 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Shelly Gupta ceased to be Additional Director on 27 Sep 2019. Urmil Jagdishmitter Gupta ceased to be Director on 25 Mar 2019. Shelly Gupta was appointed as Director on 05 Sep 2018. RX Biotech has 4 board changes on record in total.
RX Biotech can be reached through the website rxbiotech.in. Its registered office is in New Delhi, Delhi, India.
The registered office of RX Biotech is at Plot At Kh No. 1020 GF Front Side Portion Village Mundra, Extn, New Delhi, Delhi, India – 110041.
RX Biotech operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
